home / stock / tltff / tltff news

TLTFF News and Press, Theralase Technologies Inc.

Stock Information
Company Name: Theralase Technologies Inc.
Stock Symbol: TLTFF
Market: OTC
Website: theralase.com
Menu
TLTFF TLTFF Quote TLTFF Short TLTFF News TLTFF Articles TLTFF Message Board
Get TLTFF Alerts

News, Short Squeeze, Breakout and More Instantly...
TLTFF - Theralase(R) Closes $CAN 775,000 in First Tranche of Non-Brokered Private Placement

TORONTO, ON / ACCESSWIRE / July 8, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (" PDCs ...
TLTFF - Rutherrin(R) Repurposes Non-Cancer Drugs for Cancer Therapy

TORONTO, ON / ACCESSWIRE / June 20, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...

TLTFF - Rutherrin(R) Demonstrates Complete Response in Lung Cancer Preclinically

TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...

TLTFF - Rutherrin(R) Increases Efficacy of Immunotherapy Preclinically

TORONTO, ON / ACCESSWIRE / June 18, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TLTFF - Reminder Notice of Annual General and Special Meeting for Shareholders of Theralase(R)

TORONTO, ON / ACCESSWIRE / April 14, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their form...

TLTFF - Rutherrin(R) Increases Efficacy of Chemotherapy

TORONTO, ON / ACCESSWIRE / June 12, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...

TLTFF - Ruvidar(TM) Enhances Efficacy of Cancer Drug

TORONTO, ON / ACCESSWIRE / June 10, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules for the safe an...
TLTFF - Theralase Technologies Inc. (TLTFF) Q1 2024 Earnings Call Transcript

2024-06-06 14:34:08 ET Theralase Technologies Inc. (TLTFF) Q1 2024 Results Conference Call June 06, 2024 11:00 AM ET Company Participants Matthew Perraton - Chairman of the Board Kristina Hachey - Chief Financial Officer Roger Dumoulin-White - President and Chief...

TLTFF - Theralase(R) Successfully Destroys Lung Cancer

TORONTO, ON / ACCESSWIRE / June 6, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ) is a clinical stage pharmaceutical company that is dedicated to the research and development of light and/or radiation activated small molecules for th...

TLTFF - Theralase(R) Technology Effective in Virus Inactivation

TORONTO, ON / ACCESSWIRE / June 4, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules for the safe and...
Next 10